157 related articles for article (PubMed ID: 30304835)
1. Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2.
Maiuthed A; Ninsontia C; Erlenbach-Wuensch K; Ndreshkjana B; Muenzner JK; Caliskan A; Husayn AP; Chaotham C; Hartmann A; Vial Roehe A; Mahadevan V; Chanvorachote P; Schneider-Stock R
Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30304835
[TBL] [Abstract][Full Text] [Related]
2. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells.
Yoo BH; Berezkin A; Wang Y; Zagryazhskaya A; Rosen KV
Int J Cancer; 2012 Jul; 131(2):357-66. PubMed ID: 21834075
[TBL] [Abstract][Full Text] [Related]
4. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
Kim HJ; Han YS; Lee JH; Lee SH
Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
[TBL] [Abstract][Full Text] [Related]
5. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
[TBL] [Abstract][Full Text] [Related]
6. The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein (p21(WAF-1)) and anti-apoptotic protein (bcl-2) in breast cancer cells.
Chow LW; Loo WT
Breast Cancer Res Treat; 2003 Aug; 80(3):239-44. PubMed ID: 14503796
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic Localization of Cyclin Kinase Inhibitor p21 Delays the Progression of Apoptosis.
Arai D; Nomura N; Fukuchi K; Gomi K
Cancer Genomics Proteomics; 2006; 3(1):29-37. PubMed ID: 31394639
[TBL] [Abstract][Full Text] [Related]
8. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil.
Yang H; Xie S; Liang B; Tang Q; Liu H; Wang D; Huang G
J Cancer; 2021; 12(16):4862-4872. PubMed ID: 34234856
[TBL] [Abstract][Full Text] [Related]
9. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
10. Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines.
Didelot C; Mirjolet JF; Barberi-Heyob M; Ramacci C; Teiten MH; Merlin JL
Int J Oncol; 2003 Jul; 23(1):81-7. PubMed ID: 12792779
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Caffeine and chk2 Inhibitor on Doxorubicin-Induced Cellular Senescence in MCF-7 Cells.
Mohammadrezaei FM; Movaghar AF; Gharghabi M
Drug Res (Stuttg); 2016 Sep; 66(9):450-454. PubMed ID: 27403577
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells.
Ballout F; Monzer A; Fatfat M; Ouweini HE; Jaffa MA; Abdel-Samad R; Darwiche N; Abou-Kheir W; Gali-Muhtasib H
Oncotarget; 2020 Aug; 11(31):2959-2972. PubMed ID: 32821342
[TBL] [Abstract][Full Text] [Related]
14. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
15. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.
Aliouat-Denis CM; Dendouga N; Van den Wyngaert I; Goehlmann H; Steller U; van de Weyer I; Van Slycken N; Andries L; Kass S; Luyten W; Janicot M; Vialard JE
Mol Cancer Res; 2005 Nov; 3(11):627-34. PubMed ID: 16317088
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
Daskalaki W; Wardelmann E; Port M; Stock K; Steinestel J; Huss S; Sperveslage J; Steinestel K; Eder S
Int J Mol Med; 2018 Dec; 42(6):3269-3277. PubMed ID: 30272263
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients.
Xia W; Chen JS; Zhou X; Sun PR; Lee DF; Liao Y; Zhou BP; Hung MC
Clin Cancer Res; 2004 Jun; 10(11):3815-24. PubMed ID: 15173090
[TBL] [Abstract][Full Text] [Related]
18. Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancer.
Chen CR; Wang W; Rogoff HA; Li X; Mang W; Li CJ
Cancer Res; 2005 Jul; 65(14):6017-21. PubMed ID: 16024600
[TBL] [Abstract][Full Text] [Related]
19. CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil.
Yamamoto N; Yokoyama S; Ieda J; Mitani Y; Yamaguchi S; Takifuji K; Hotta T; Matsuda K; Watanabe T; Shively JE; Yamaue H
Cancer Chemother Pharmacol; 2015 Feb; 75(2):421-30. PubMed ID: 25547406
[TBL] [Abstract][Full Text] [Related]
20. E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy.
Sulzyc-Bielicka V; Domagala P; Bielicki D; Safranow K; Rogowski W; Domagala W
Pathol Oncol Res; 2016 Jul; 22(3):601-8. PubMed ID: 26831819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
